The current study, for the first time, demonstrates that the glomerular disease in a mouse model of anti-GBM-GN is associated with impaired Nrf2 activation (reduced nuclear content) along with low levels of GCLc, GCLm, and GPx1. Here, GCLC is linked to glioblastoma.